Open Label Dose Escalation Phase I Study to Investigate the Safety and Pharmacokinetics of T121E01F and T121E02F in Healthy Postmenopausal Women

NCT01721993 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Postmenopausal Women

Interventions

DRUG: T121
DRUG: Zoledronic acid

Sponsor

Thar Pharmaceuticals, Inc